鼻内镜下泪前隐窝联合中鼻道入路治疗上颌窦复发性乳头状瘤的临床研究

Clinical study on the treatment of recurrent papilloma of maxillary sinus by anterior lacrimal recess and middle nasal canal approach with nasal endoscope

目的探讨鼻内镜下泪前隐窝+中鼻道(开窗术)入路治疗上颌窦复发性内翻性乳头状瘤的临床效果。方法治疗组对上颌窦复发性内翻性乳头状瘤患者60例采用鼻内镜下泪前隐窝+中鼻道(开窗术)入路治疗;对照组回顾总结既往单纯采用中鼻道上颌窦(开窗术)入路治疗上颌窦复发性内翻性乳头状瘤病例50例,观察术后复发率、术中术后并发症等情况。结果所有病例均经一年以上随访。治疗组治愈率占95%,复发率为5%,术中术后均未见明显并发症发生;对照组治愈率占70%,复发率为30%。结论本联合术式视野更清晰,清除病变较彻底,术后复发率低,值得临床推广应用。

Objective To investigate the clinical effect of anterior lacrimal recess and middle nasal canal（fenestration）approach with nasal endoscope for treating recurrent inverted papilloma of the maxillary sinus. Methods The patients with recurrent inverted papilloma of maxillary sinus in the treatment group（60 cases）were treated with the approach of nasal endoscopic anterior lacrimal recess and middle meatus（fenestration）. A retrospective summary of recurrent inverted papilloma of maxillary sinus treated by middle nasal canal approach（fenestration）was as control group（50 cases）. The postoperative recurrence rate and the postoperative complications of surgery were observed. Results All cases were followed up for more than one year. The cure rate of the treatment group was 95%,and the recurrence rate was 5%. No obvious complications were found in the postoperative operation. Meanwhile,the cure rate of the control group was 70%,and the recurrence rate was 30%. Conclusion This combined operation makes the vision clearer,clears the lesion thoroughly,and has a low recurrence rate. It is worthy of clinical promotion.